Validation of a Generalized Transfer Function to Noninvasively Derive Central Blood Pressure During Exercise

  • James E. Sharman
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Richard Lim
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Ahmad M. Qasem
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Jeff S. Coombes
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Malcolm I. Burgess
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Jeff Franco
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Paul Garrahy
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Ian B. Wilkinson
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.
  • Thomas H. Marwick
    From the Department of Medicine (J.E.S., M.I.B., T.H.M.), School of Human Movement Studies (J.E.S., J.S.C.), and Department of Cardiology (R.L., J.F., P.G.), University of Queensland, Princess Alexandra Hospital, Queensland, Australia; Department of Engineering (A.M.Q.), University of New South Wales, Sydney, Australia; and Clinical Pharmacology Unit (I.B.W.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom.

抄録

<jats:p> Exercise brachial blood pressure (BP) predicts mortality, but because of wave reflection, central (ascending aortic) pressure differs from brachial pressure. Exercise central BP may be clinically important, and a noninvasive means to derive it would be useful. The purpose of this study was to test the validity of a noninvasive technique to derive exercise central BP. Ascending aortic pressure waveforms were recorded using a micromanometer-tipped 6F Millar catheter in 30 patients (56±9 years; 21 men) undergoing diagnostic coronary angiography. Simultaneous recordings of the derived central pressure waveform were acquired using servocontrolled radial tonometry at rest and during supine cycling. Pulse wave analysis of the direct and derived pressure signals was performed offline (SphygmoCor 7.01). From rest to exercise, mean arterial pressure and heart rate were increased by 20±10 mm Hg and 15±7 bpm, respectively, and central systolic BP ranged from 77 to 229 mm Hg. There was good agreement and high correlation between invasive and noninvasive techniques with a mean difference (±SD) for central systolic BP of −1.3±3.2 mm Hg at rest and −4.7±3.3 mm Hg at peak exercise (for both <jats:italic>r</jats:italic> =0.995; <jats:italic>P</jats:italic> <0.001). Conversely, systolic BP was significantly higher peripherally than centrally at rest (155±33 versus 138±32 mm Hg; mean difference, −16.3±9.4 mm Hg) and during exercise (180±34 versus 164±33 mm Hg; mean difference, −15.5±10.4 mm Hg; for both <jats:italic>P</jats:italic> <0.001). True myocardial afterload is not reliably estimated by peripheral systolic BP. Radial tonometry and pulse wave analysis is an accurate technique for the noninvasive determination of central BP at rest and during exercise. </jats:p>

収録刊行物

  • Hypertension

    Hypertension 47 (6), 1203-1208, 2006-06

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ